Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
mld10 (1 trial)
magnesium lactate (1 trial)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Migraine Disorders (Phase 3)
Trials (2 total)
Trial APIs (2 total)